Bharat Biotech submits new request to Brazilian regulator on GMP issues for Covaxin

Bharat Biotech submits new request to Brazilian regulator on GMP issues for Covaxin

According to the National Health Surveillance Agency of Brazil Anvisa, Bharat Biotech made the request on May 25 and a day before the Ministry of Health of the South American country filed a new application for authorisation to import 20 million doses of the Covaxin.
Check the source here –Source, Financial Express.
Change Language